Cutaneous Lupus Erythematosus: Overview and Treatment

January 2017 in “ Springer eBooks ”

Christopher B. Hansen, David Fiorentino, Richard D. Sontheimer

cutaneous lupus erythematosus CLE acute cutaneous lupus erythematosus ACLE subacute cutaneous lupus erythematosus SCLE chronic cutaneous lupus erythematosus CCLE discoid lupus erythematosus DLE systemic lupus erythematosus SLE butterfly rash photosensitivity scarring pigmentary changes HLA haplotypes TNF-α promoter polymorphisms UV light sun protection corticosteroids calcineurin inhibitors antimalarials thalidomide lenalidomide immunosuppressives IVIG intravenous immunoglobulin monoclonal antibodies T lymphocytes TLR signaling

Studysummary This article reviews the classification, pathogenesis, and treatment options for cutaneous lupus erythematosus and reports no new clinical findings.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

Read the full study on link.springer.com →

Discuss this study in the Community →

Similar research 5

Cutaneous Lupus Erythematosus: A Review Dermatologic clinics · 2002
Cutaneous Lupus Erythematosus: Clinico-Pathologic Correlation Italian Journal of Dermatology and Venereology · 2018
Skin Elsevier eBooks · 2011
Lupus Erythematosus and the Skin Elsevier eBooks · 2004
Cutaneous Lupus Erythematosus Dalhousie Medical Journal · 2013

Related Community Posts Join

6 / 1000+ results

community cb-03-01 research chem (winlevi/clascoterone cream)

in Technology 3 upvotes 2 years ago

The user is considering using CB or clascoterone for hair loss, potentially as an alternative to RU. They're also contemplating asking a dermatologist for topical clascoterone cream to apply to their temple.

community EMA is re-examining Winlevi (clascoterone at lower concentration)

8 upvotes 1 year ago

Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.

community Women complaining of bad effects from Winlevi (Clascoterone 1%)

11 upvotes 9 months ago

Women experienced severe reactions, including Topical Steroid Withdrawal (TSW), from using Winlevi (Clascoterone 1%) on their faces. Concerns were raised about the potential risks of higher concentrations, especially for hair loss treatment.

community Winlevi Clascoterone- resultssss

4 upvotes 1 week ago

The conversation is about using Winlevi Clascoterone cream for hair loss. The user is considering adding it to their routine, which includes a topical hair growth serum, and is seeking feedback on its effectiveness.

community Hives/Rash from Kx 826 Pyrilutamide???

1 upvotes 1 year ago

OP developed hives after using Kx 826 (Pyrilutamide) 1% twice daily for 3 weeks. The hives appeared on the arms, chest, and groin area.

community Whatever happened to Clascoterone? (breezula for hair) (sold as Winlevi for acne available since 2021)

4 upvotes 3 weeks ago

Clascoterone (Breezula) is anticipated for release in the coming years but is considered too weak for aggressive androgenetic alopecia (AGA). Current treatments like minoxidil, finasteride, and dutasteride are preferred, with some users obtaining clascoterone from the gray market.